Is a treatment for pregnancy sickness on its way? - Tech & Science Daily podcast

All the stories from Thursday's episode of the Tech & Science Daily podcast.
A study found the hormone GDF15 is responsible for sickness during pregnancy.
PA Archive
Jon Weeks14 December 2023

Professor Sir Stephen O’Rahilly tells Tech & Science Daily that levels of the hormone produced in the placenta as well as the pregnant woman’s sensitivity to it dictate how severe their sickness will be.

Professor O’Rahilly discusses the potential treatment options for pregnant women and those who suffer from extreme sickness, and a condition called hyperemesis.

The pill, called YCT-529, is a drug called a retinoic acid receptor-alpha inhibitor, and prevents sperm production by blocking access to vitamin A.

Experts from YourChoice Therapeutics said that pre-clinical studies showed YCT-529 was “99% effective and 100% reversible with no side effects”.

Scientists hope that if the tests are successful, the daily pill could broaden shared responsibility for contraception between the sexes.

It’s thought a new substance discovered by scientists could knock diamonds off the top spot, as the hardest material on earth.

They are called carbon nitrides, and are formed when carbon and nitrogen molecules are subjected to extreme heat and pressure.

Researchers have been trying to unlock the potential of carbon nitrides since the 1980s, and the recent discovery showed they were tougher than cubic boron nitride, the second hardest material after diamonds.

Also in this episode:

Tesla recalls more than two million cars in the US over autopilot concerns, how to watch the Geminids meteor shower on Thursday night, social media platform Threads will let you push fact-checked posts further down your feed, and revealed: the cost of replacing the Tesla Cybertruck’s infamous windscreen wiper.

Listen above, find us on Apple, Spotify or wherever you stream your podcasts.

Create a FREE account to continue reading

eros

Registration is a free and easy way to support our journalism.

Join our community where you can: comment on stories; sign up to newsletters; enter competitions and access content on our app.

Your email address

Must be at least 6 characters, include an upper and lower case character and a number

You must be at least 18 years old to create an account

* Required fields

Already have an account? SIGN IN

By clicking Create Account you confirm that your data has been entered correctly and you have read and agree to our Terms of use , Cookie policy and Privacy policy .

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged in